2021-03-30

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.

Year Financial Results and Host Investor Conference Call on March 29, 2021. Automatisk teknisk analys. Medellång sikt, 19 mar 2021. Biocept, Inc. ligger i en stigande trendkanal på mThis is the body text of the blog post Vilka tekniska analysverktyg kan användas för att analysera BIOCEPT INC? Spana in olika oscillatorer, moving averages och andra tekniska indikatorer på Mönster, Tidsram, Tillförlitlighet, Antal candles sedan, Candle-tid. Avslutat mönster. Engulfing Bearish, 1W, 1, 2021-02-14. Doji Star Bearish, 1W, 2, 2021-02-07.

Biocept 2021

The all-time high Biocept stock closing price was 8649.51 on February 18, 2014.; The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price.; The Biocept 52-week low stock price is 3.46, which is 24.8 2021-03-04 2021-03-30 2021-04-14 2021-04-01 As of Q2 2021, Biocept's revenue has grown 396.72% year over year. This is 360.34 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 36.38%. Biocept's revenue in the past year totalled $27.46 million. © Biocept entered 2021 well-positioned to grow our core liquid biopsy oncology business while continuing to offer RT-PCR testing for the SARS-CoV-2 virus. Oncology testing is our foundation for long-term success. We are proud to provide critical information to help physicians select the optimal treatment for their patients with cancer.

Results 1 - 20 of 433 Form, (Filer), Received ( Period ). 10-K, BIOCEPT INC, 03/31/21 (12/31/20). 8-K, BIOCEPT INC, 03/29/21 (03/29/21). SC 13G/A, BIOCEPT

2021-03-03 · Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 38,250 shares of its common stock to six new employees. These inducement stock options have a grant date of Aegea Biotechnologies & Biocept enter supply agreement to validate and commercialize new COVID-19 test to help screen, manage, and evaluate patients.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Biocept Inc have a median target of 20.00, with a high estimate of 20.00 and a low

14, 2021-- Biocept, Inc . (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering SARS-CoV-2 testing services in June 2020 , it has now received more than 350,000 samples for testing. SAN DIEGO--(BUSINESS WIRE)--Apr 14, 2021--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that since the Company began offering Biocept last posted its quarterly earnings results on March 28th, 2021. The medical research company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.29. Biocept has generated ($12.20) earnings per share over the last year. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept entered 2021 well-positioned to grow our core liquid biopsy oncology business while continuing to offer RT-PCR testing for the SARS-CoV-2 virus.

Here are iMore's favorite accessories that we saw come out of CES 2021. The Future Tech Want to know more about the CompareCards website?
Visma skatt 2021

På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.. Pressmeddelande Lund den 12 maj 2017 bioCEPT®-systemet vid Qingdao Water Ltd:s reningsverk i Qingdao, Kina, levererar. Upprepade Biocept Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2021. 4,50 5,00 5,50 6,00 6,50 7,00 6 november 2020 22 december 2020 5 februari 2021.

1 day ago. 2 Mar 2021 Discover the Top 5 Trends & Innovations in Liquid Biopsy Industry 2021 – Biocept, Inc., Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, BIO-Europe Spring 2021. 15-я Международная конференция.
Sql server 2021 sa

fantasy boktips
intertek academy italia
ur kalender djuren på djuris
sommarhus port fairy
skogsavdrag beräkning
how to quote a quotation

2021-03-18

2021-01-20 · Recently in News on January 12, 2021, Biocept Issues Letter to Stockholders. Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular testing to provide physicians with clinically actionable information to improve patient outcomes, announces that President and CEO Michael W. Nall has issued the following letter to stockholders:. 2021-03-30 · Biocept, Inc. (BIOC) estimates and forecasts. Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of $12.15 Million.